Basal Protein Expression Is Associated With Worse Outcome and Trastuzamab Resistance in HER2+ Invasive Breast Cancer
Clinical Breast Cancer - United States
doi 10.1016/j.clbc.2015.06.001
Full Text
Open PDFAbstract
Available in full text
Date
December 1, 2015
Authors
Publisher
Elsevier BV